ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
A target for potential cancer drugs may, in fact, worsen disease
November 11, 2021In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2. -
InnoCare Announces Approval of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China
October 19, 2021InnoCare Pharma (HKEX: 09969) announced today that the Company has received Investigational New Drug (IND) approval from the NMPA for its SHP2 (Src Homology 2 domain containing protein tyrosine phosphatase) allosteric inhibitor ICP-189... -
AbbVie partners with Jacobio Pharmaceuticals for cancer drugs
June 03, 2020AbbVie has collaborated with Jacobio Pharmaceuticals for the development and commercialisation of SHP2 inhibitors that act on an important node in cancer and immune cells.
Pharma Sources Insight January 2025
